You just read:

Eloxx Pharmaceuticals Expands Management Team to Support Rapid Development of Lead Drug Candidate ELX-02 for the Treatment of Rare Genetic Diseases

News provided by

Eloxx Pharmaceuticals

Sep 08, 2017, 08:00 ET